
|Articles|March 22, 2007
Vasogen Names Terry H. Gregg President and CEO
Author(s)BioPharm International Editors
Vasogen, Inc. (Ontario, Canada, www.vasogen.com), has appointed Terrance H. Gregg to succeed David G. Elsley as president and CEO of Vasogen.
Advertisement
Vasogen, Inc. (Ontario, Canada,
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
2
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
3
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
4
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
5




